Global Advanced Cell & Gene
Therapy CDMO

Your Innovative Partner from Development to Commercialization

Our Capabilities

Bringing Your Cell & Gene Therapy Products to the Market

We commit to delivering the highest-quality contract development and manufacturing services to our partners

Process & Analytical Development

Begin with the end in mind

cGMP Cell Banking

cGMP Cell Banking

Accelerate your Cell Bank Production


Manufacturing Science & Technology

A comprehensive approach to technology transfer


Clinical & Commercial Manufacturing

Delivering innovative, life-changing cell therapies


Quality & Regulatory Compliance

A holistic innovative approach to quality

RoslinCT-LN2 -room-worker

Supply Chain & Logistics

Managing logistics with patients in mind

Success Powered by Cutting-Edge Science

RoslinCT, as one of the first in the world to produce clinical-grade human pluripotent stem cells, has a strong focus on science and innovation. In collaboration with Vertex Pharmaceuticals, RoslinCT developed, from early process development through commercialization, the First CRISPR-Edited Cell Therapy Product, exa-cel for the treatment of sickle cell disease and transfusion-dependent beta thalassemia.
200 +

cGMP Batches Produced

for various indications

22 +

cGMP Suites

allowing simultaneous processing

350 +

Experienced Employees

across two continents

20 +

Cell Types

experience supporting auto and allo processes

Purpose-Built cGMP Manufacturing Facilities

Benefit from our world-class, innovative cell therapy development and cGMP manufacturing facilities

About RoslinCT

Get to Know the Team and What We Stand for

Innovative Solutions. Trusted Partnerships. Life-changing Treatments.

Following the world-breaking first cloning of a mammal (Dolly the Sheep) at the Roslin Institute within the University of Edinburgh (UK) in 1997, there was worldwide interest to access Roslin’s technology and expertise. RoslinCT was established in 2006 to translate this cutting-edge science and apply it to the development of human medicines.

To save the lives of patients by empowering our partners to efficiently progress cell & gene therapies from development to commercialization, as their advanced CDMO partner of choice.

We are a team of passionate professionals with decades of experience in the advanced cell & gene therapy industry.

The Scientific Advisory Board is comprised of cell and gene therapy pioneers with extensive domain experience.

  • Deep Scientific Expertise and Diversity of Cell Platform Experience
  • The One of the First in the World to Produce Clinical-Grade Human Pluripotent Cells
  • Advanced Program Utilizing Vertex Pharmaceutical’s CRISPR-Edited Stem Cell-Based Therapy
  • Process and Analytical Development Laboratory
  • Clinical and Commercial Manufacturing Capacity
  • Integration of Best-in-Class Cell Therapy Software Solutions
  • Extensive Training
  • Adaptive Approach to Partner Relationships
Choose a Career with Purpose

Accelerate Your Future
with RoslinCT